Experiences and Lessons From Implementing Cohort Event Monitoring Programmes for Antimalarials in Four African Countries: Results of a Questionnaire-Based Survey.

作者： Comfort Kunak Suku , Geraldine Hill , George Sabblah , Mimi Darko , George Muthuri

关键词: Prescription event monitoring 、 Medicine 、 Cohort 、 Prospective cohort study 、 Family medicine 、 Public health 、 Optometry 、 Cohort study 、 Pharmacovigilance 、 Event monitoring 、 Adverse effect

摘要: Introduction Cohort event monitoring (CEM) is an intensive method of post-marketing surveillance for medicines safety. The based on prescription monitoring, which began in the 1970s, and has since been adapted by WHO safety used Public Health Programmes. CEM aims to capture all adverse events that occur a defined group patients after starting treatment with specific medicine during course routine clinical practice.

参考文章(17)

Nabarro D, Roll Back Malaria. Parassitologia. ,vol. 41, pp. 501- 504 ,(1999)

I. R. Edwards, Safety monitoring of new anti-malarials in immediate post-marketing phase. Médecine tropicale : revue du Corps de santé colonial. ,vol. 58, pp. 93- 96 ,(1998)

Deborah Layton, Saad Shakir, Prescription-Event Monitoring (PEM): The Evolution to the New Modified PEM and its Support of Risk Management Mann's Pharmacovigilance. pp. 359- 384 ,(2014) , 10.1002/9781118820186.CH22

Mira Harrison-Woolrych, Prescription-Event Monitoring in New Zealand Mann's Pharmacovigilance. pp. 385- 402 ,(2014) , 10.1002/9781118820186.CH23

Ambrose O Talisuna, Sarah G Staedke, Umberto D'Alessandro, Pharmacovigilance of antimalarial treatment in Africa: is it possible? Malaria Journal. ,vol. 5, pp. 50- 50 ,(2006) , 10.1186/1475-2875-5-50

Alison Gillwald, CHRISTOPH Stork, ENRICO Calandro, ALISON Gillwald, Internet going mobile: internet access and use in 11 African countries Info. ,vol. 15, pp. 34- 51 ,(2013) , 10.1108/INFO-05-2013-0026

S. Cederholm, G. Hill, A. Asiimwe, A. Bate, F. Bhayat, G. Persson Brobert, T. Bergvall, D. Ansell, K. Star, G. N. Norén, Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network. Drug Safety. ,vol. 38, pp. 87- 100 ,(2015) , 10.1007/S40264-014-0251-Y

Alexander N. O. Dodoo, Carole Fogg, Edmund T. Nartey, Germano L. C. Ferreira, George Obeng Adjei, William Kudzi, Abdul Malik Sulley, Augustina Kodua, David Ofori-Adjei, Profile of Adverse Events in Patients Receiving Treatment for Malaria in Urban Ghana: A Cohort-Event Monitoring Study Drug Safety. ,vol. 37, pp. 433- 448 ,(2014) , 10.1007/S40264-014-0164-9

Shanthi N. Pal, Sten Olsson, Elliot G. Brown, The monitoring medicines project: a multinational pharmacovigilance and public health project. Drug Safety. ,vol. 38, pp. 319- 328 ,(2015) , 10.1007/S40264-015-0283-Y

10.

Peter Usman Bassi, Adeline I. Osakwe, Ambrose Isah, Comfort Suku, Musa Kalat, Iliya Jalo, Robinson Daniel Wammanda, Chika Ugochukwu, Olubukula Adesina, Eno Etim Nyong, Frank Osungwu, Shanti Pal, Sylvester Chigozie Nwoasu, Magnus Wallberg, David Coulter, Safety of Artemisinin-Based Combination Therapies in Nigeria: A Cohort Event Monitoring Study Drug Safety. ,vol. 36, pp. 747- 756 ,(2013) , 10.1007/S40264-013-0044-8

Experiences and Lessons From Implementing Cohort Event Monitoring Programmes for Antimalarials in Four African Countries: Results of a Questionnaire-Based Survey.

来源期刊

我的账户

Experiences and Lessons From Implementing Cohort Event Monitoring Programmes for Antimalarials in Four African Countries: Results of a Questionnaire-Based Survey.

来源期刊

相似文章 10

我的账户